Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0899
Host Cell : NCI-H146 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0899 |
| Description | This cell line is engineered to stably overexpress human CD274 (also named as PDL1). |
| Target Gene | CD274 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | NCI-H146 |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | CD274 CD274 molecule [ Homo sapiens ] |
| Gene Symbol | CD274 |
| Synonyms | CD274; CD274 molecule; CD274 antigen , PDCD1LG1, programmed cell death 1 ligand 1; programmed cell death 1 ligand 1; B7 homolog 1; B7 H; B7 H1; B7H1; PD L1; PDL1; CD274 antigen; PDCD1 ligand 1; programmed death ligand 1; B7-H; PD-L1; PDCD1L1; PDCD1LG1; MGC142294; MGC142296; |
| Gene ID | 29126 |
| Uni Prot ID | Q9NZQ7 |
| m RNA Refseq | BC113734 |
| Chromosome Location | 9p24.1 |
| Function | protein binding; protein tyrosine phosphatase activity; receptor activity; |
| Pathway | Adaptive Immune System, organism-specific biosystem; Cell adhesion molecules (CAMs), organism-specific biosystem; Cell adhesion molecules (CAMs), conserved biosystem; Costimulation by the CD28 family, organism-specific biosystem; Immune System, organism-specific biosystem; PD-1 signaling, organism-specific biosystem; |
| MIM | 605402 |
A: The Human CD274 Stable Cell Line - NCI-H146 is a stable cell line derived from the human lung cancer cell line NCI-H146. This cell line has been stably transfected or engineered to express the CD274 gene, also known as PD-L1 (Programmed Death-Ligand 1). PD-L1 is an immune checkpoint molecule associated with immune evasion in cancer. This cell line is used for research in immunotherapy, immune checkpoint inhibitors, and cancer immune evasion mechanisms.
A: NCI-H146 was chosen as the source for the Human CD274 Stable Cell Line because it is a human lung cancer cell line commonly used in lung cancer and immunotherapy research. PD-L1 (CD274) expression in lung cancer is closely associated with immune evasion, making this cell line valuable for studying the biological functions of PD-L1 and drug screening for PD-L1 inhibitors.
A: PD-L1 (CD274) gene expression in the Human CD274 Stable Cell Line - NCI-H146 is typically achieved through stable gene expression or transfection. These cells are maintained under appropriate culture conditions, which often involve the addition of suitable culture media and antibiotics to sustain gene expression. Regular passaging and monitoring of the cells are crucial for maintaining stability.
A: The Human CD274 Stable Cell Line - NCI-H146 has broad potential in immunotherapy research. It can be used to assess the effectiveness of PD-L1 inhibitors, study the mechanisms of immune checkpoint inhibitors, and develop new immunotherapy strategies, including CAR-T cell therapy and cancer vaccines.
A: PD-L1 (CD274) is an important target in immune checkpoint inhibitor therapy. It inhibits T cell activation by interacting with the PD-1 receptor, thereby helping cancer cells evade immune attack. Inhibiting the interaction between PD-L1 and PD-1 can restore T cell activation, enhance immune responses, and improve resistance against tumors.
A: The Human CD274 Stable Cell Line - NCI-H146 can be used to study various types of immune checkpoint inhibitors, including anti-PD-L1 antibodies, anti-PD-1 antibodies, and other related immunotherapy drugs. This helps evaluate their efficacy and mechanisms.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.